ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis

With an integrated suite of advanced analytical tools, purpose-built to unlock deeper biological insights from complex cellular data, MorphoScan Cloud is the next step in ThinkCyte's commitment to bringing advanced morphometric profiling hardware and software solutions to life science research. Whether applying supervised or unsupervised learning techniques, users will be able to leverage cloud computing  to explore their datasets using advanced  algorithms including deep learning. With an...

With an integrated suite of advanced analytical tools, purpose-built to unlock deeper biological insights from complex cellular data, MorphoScan Cloud is the next step in ThinkCyte's commitment to bringing advanced morphometric profiling hardware and software solutions to life science research. Whether applying supervised or unsupervised learning techniques, users will be able to leverage cloud computing  to explore their datasets using advanced  algorithms including deep learning.

"With MorphoScan Cloud, we're providing our customers with more than just storage - we're offering an intelligent platform that transforms how research teams engage with cellular data," said Waichiro Katsuda, CEO of ThinkCyte. "By combining the new view of biology provided by VisionSort with the analytical power of AI with the accessibility of the cloud, we aim to streamline data analysis workflows, accelerate discovery, and empower innovation across the life sciences."

Attendees at CYTO 2025 can experience MorphoScan Cloud firsthand at the ThinkCyte booth (#627) or more information, visit https://thinkcyte.com/mkt/morphoscan-cloud/

About ThinkCyte

ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific research platforms based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. The company developed Ghost Cytometry™, a proprietary AI-based, label-free cell analysis and sorting technology and partners with major global biopharmaceutical companies and leading academic research institutes to drive pioneering research. For more information, please visit www.thinkcyte.com.

Logo - https://mma.prnewswire.com/media/2605983/ThinkCyte_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/thinkcyte-unveils-morphoscan-cloud-a-versatile-cloud-based-platform-for-ai-driven-cell-morphology-data-analysis-302472135.html